Have a personal or library account? Click to login
Developing a diagnostic test to identify the selected mutation within the CFTR gene that determines the onset of cystic fibrosis Cover

Developing a diagnostic test to identify the selected mutation within the CFTR gene that determines the onset of cystic fibrosis

Current Issues in Pharmacy and Medical Sciences
Volume 31 (2018): Issue 4 (December 2018)
By: Angelika Szymczak,  Piotr Ksiazek,  Sylwia Mojsym-Korybska,  Wojciech Skorupa and  Albertyna Zbikowska-Machul  
Open Access
|Jan 2019

Metrics

DOI: https://doi.org/10.1515/cipms-2018-0037 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 200 - 203
Submitted on: Mar 14, 2018
|
Accepted on: May 24, 2018
|
Published on: Jan 3, 2019
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
CF – cystic fibrosis,
CFTR – cystic fibrosis transmembrane conductance regulator,
EnaC – epithlial sodium channel,
ROMK – renal outermedullary potassium channel,
ORCC – outwardly rectifying chloride channel,
CBAVD – congenital bilateral absence of the vas deferent,
WHO – World Health Organization,
ECFTN – European Cystic Fibrosis Society,
PCR – polymerase chain reaction
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Pharmacology, toxicology,
Pharmacy,
Pharmacy, other

© 2019 Angelika Szymczak, Piotr Ksiazek, Sylwia Mojsym-Korybska, Wojciech Skorupa, Albertyna Zbikowska-Machul, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 31 (2018): Issue 4 (December 2018)Next article